•
Jun 30, 2019

Arrowhead Pharmaceuticals Q3 2019 Earnings Report

Total Revenue
$42.7M
Previous year: $727K
+5770.0%
EPS
$0.21
Previous year: -$0.18
-216.7%
Gross Profit
$42.7M
Previous year: $727K
+5770.0%
Cash and Equivalents
$188M
Previous year: $28M
+572.7%
Free Cash Flow
$7.3M
Previous year: -$14.6M
-150.0%
Total Assets
$337M
Previous year: $113M
+198.3%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals